Last reviewed · How we verify
ranibizumab, aflibercept, pegaptanib, verteporphin
ranibizumab, aflibercept, pegaptanib, verteporphin is a Small molecule drug developed by Kagawa University. It is currently FDA-approved. Also known as: Lucentis, Eylea, Macugen, Vizudyne.
At a glance
| Generic name | ranibizumab, aflibercept, pegaptanib, verteporphin |
|---|---|
| Also known as | Lucentis, Eylea, Macugen, Vizudyne |
| Sponsor | Kagawa University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cohort Study of the Clinical Course of Macular Diseases in Kagawa (PHASE4)
- Cohort Study of the Clinical Course of Macular Diseases in Japanese
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ranibizumab, aflibercept, pegaptanib, verteporphin CI brief — competitive landscape report
- ranibizumab, aflibercept, pegaptanib, verteporphin updates RSS · CI watch RSS
- Kagawa University portfolio CI
Frequently asked questions about ranibizumab, aflibercept, pegaptanib, verteporphin
What is ranibizumab, aflibercept, pegaptanib, verteporphin?
ranibizumab, aflibercept, pegaptanib, verteporphin is a Small molecule drug developed by Kagawa University.
Who makes ranibizumab, aflibercept, pegaptanib, verteporphin?
ranibizumab, aflibercept, pegaptanib, verteporphin is developed and marketed by Kagawa University (see full Kagawa University pipeline at /company/kagawa-university).
Is ranibizumab, aflibercept, pegaptanib, verteporphin also known as anything else?
ranibizumab, aflibercept, pegaptanib, verteporphin is also known as Lucentis, Eylea, Macugen, Vizudyne.
What development phase is ranibizumab, aflibercept, pegaptanib, verteporphin in?
ranibizumab, aflibercept, pegaptanib, verteporphin is FDA-approved (marketed).
Related
- Manufacturer: Kagawa University — full pipeline
- Also known as: Lucentis, Eylea, Macugen, Vizudyne
- Compare: ranibizumab, aflibercept, pegaptanib, verteporphin vs similar drugs
- Pricing: ranibizumab, aflibercept, pegaptanib, verteporphin cost, discount & access